Inhibikase Therapeutics, Inc. - Price History
Monthly price history for IKT (Inhibikase Therapeutics, Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| May 2024 | $1.39 | $1.39 |
| April 2024 | $1.47 | $1.47 |
| March 2024 | $2.16 | $2.16 |
| February 2024 | $2.16 | $2.16 |
| January 2024 | $3.02 | $3.02 |
| December 2023 | $1.27 | $1.27 |
| November 2023 | $0.94 | $0.94 |
| October 2023 | $0.89 | $0.89 |
| September 2023 | $1.39 | $1.39 |
| August 2023 | $2.01 | $2.01 |
| July 2023 | $2.52 | $2.52 |
| June 2023 | $3.61 | $3.61 |
| May 2023 | $4.13 | $0.69 |
| April 2023 | $3.35 | $0.56 |
| March 2023 | $3.95 | $0.66 |
| February 2023 | $4.43 | $0.74 |
| January 2023 | $4.24 | $0.71 |
| December 2022 | $3 | $0.50 |
| November 2022 | $3.63 | $0.60 |
| October 2022 | $4.63 | $0.77 |
| September 2022 | $5.46 | $0.91 |
| August 2022 | $5.76 | $0.96 |
| July 2022 | $5.10 | $0.85 |
| June 2022 | $4.46 | $0.74 |
| May 2022 | $5.50 | $0.92 |
| April 2022 | $6.48 | $1.08 |
| March 2022 | $8.88 | $1.48 |
| February 2022 | $6.36 | $1.06 |
| January 2022 | $8.40 | $1.40 |
| December 2021 | $8.82 | $1.47 |
| November 2021 | $12 | $2 |
| October 2021 | $11.94 | $1.99 |
| September 2021 | $11.40 | $1.90 |
| August 2021 | $14.22 | $2.37 |
| July 2021 | $13.62 | $2.27 |
| June 2021 | $16.80 | $2.80 |
| May 2021 | $32.10 | $5.35 |
| April 2021 | $31.38 | $5.23 |
| March 2021 | $36.06 | $6.01 |
| February 2021 | $40.20 | $6.70 |
| January 2021 | $39.96 | $6.66 |
| December 2020 | $41.40 | $6.90 |
IKT
Price: $1.39
52 week price:
Earnings Per Share: -3.57 USD
P/E Ratio: -0.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146895
Market Capitalization: 9.0 million